OncBioMune Pharmaceuticals, Inc | Uncategorized | Business Contracts

Offer Letter between the Company and Faith Zaslavsky, dated December 5, 2022 (Filed With SEC on December 9, 2022)

Form of 10% Original Issue Discount Senior Secured Convertible Debentures (Filed With SEC on December 1, 2022)

Form of 10% Original Issue Discount Senior Secured Convertible Debentures (Exchanged Debentures) (Filed With SEC on December 1, 2022)

Engagement Letter, by and between Carter, Terry & Company and Theralink Technologies, Inc., dated December 15, 2021, as amended (Filed With SEC on February 3, 2022)

Form of Warrants issued September 24, 2018 (Filed With SEC on November 14, 2018)

Warrants Agreement between Cavalry I LP and OncBioMune, Inc, dated November 13, 2018 (Filed With SEC on November 14, 2018)

ForbearanceAgreement (Filed With SEC on June 6, 2017)

NON-QUALIFIEDSTOCK OPTION AGREEMENT FOR DIRECTORS (Filed With SEC on April 21, 2017)

PARTIES (Filed With SEC on March 13, 2017)

Representations (Filed With SEC on March 13, 2017)

STOCKHOLDERS’AGREEMENT datedas of March10, 2017 among ONCBIOMUNEPHARMACEUTICALS, INC. and THESTOCKHOLDERS PARTY HERETO (Filed With SEC on March 13, 2017)

FORMOF (Filed With SEC on March 13, 2017)

FORMOF NON-QUALIFIEDSTOCK OPTION AGREEMENT (Filed With SEC on March 13, 2017)

AMENDEDAND RESTATED SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 28, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 21, 2016)

SABRCapital Management LLC 335 Madison Avenue, Suite 1100, New York, New York 10017 (Filed With SEC on May 16, 2016)

Account (Filed With SEC on May 16, 2016)

EMPLOYMENTAGREEMENT (Filed With SEC on February 5, 2016)

PURCHASEAGREEMENT (Filed With SEC on November 20, 2015)

PURCHASEAGREEMENT (Filed With SEC on October 26, 2015)

SHAREEXCHANGE AGREEMENT Dated June22, 2015 byand among QUINTMEDIA, INC., a Nevada Corporation asthe Acquiror and Parent. and ONCBIOMUNE,INC., aLouisiana corporation and... (Filed With SEC on June 24, 2015)

DEBTSETTLEMENT AGREEMENT (Filed With SEC on June 24, 2015)

DEBTSETTLEMENT AGREEMENT (Filed With SEC on March 16, 2015)

Co-Promotion Agreement dated February 21, 2012 with Apricus Biosciences, Inc. (portions of the exhibit have been omitted pursuant to a request for confidential treatment) (Filed With SEC on May 18, 2012)

Form of independent contractor agreement (Filed With SEC on September 30, 2011)

Co-promotion agreement with Bi-Coastal Pharmaceuticals effective September 12, 2011 (portions of the exhibit have been omitted pursuant to a request for confidential treatment) (Filed With SEC on September 14, 2011)

Lock-up Agreement dated February 9, 2011 with Cameron Durrant (Filed With SEC on February 10, 2011)

Lock-up Agreement dated February 9, 2011 with David Tousley (Filed With SEC on February 10, 2011)

Cancellation Agreement dated February 9, 2011 with Cameron Durrant (Filed With SEC on February 10, 2011)

Cancellation Agreement dated February 9, 2011 with David Tousley (Filed With SEC on February 10, 2011)

Letter of Intent with Granisol Oral Solution (Filed With SEC on June 28, 2010)

OncBioMune Pharmaceuticals, Inc (174) | Uncategorized (31)